Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Addition of sitagliptin to sulfonylurea + metformin in type 2 diabetes mellitus
2010-018318-62Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Sitagliptin arm with Placebo arm (2 arms). Primary endpoint: Change in HbA1c from baseline at Week 24. Started Apr 2010; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-018318-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018318-62.